Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
14.9M
-
Shares change
-
+2.37M
-
Total reported value, excl. options
-
$342M
-
Value change
-
+$55M
-
Number of buys
-
14
-
Number of sells
-
-12
-
Price
-
$22.87
Significant Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q2 2018
37 filings reported holding MYOV - MYOVANT SCIENCES LTD - COMMON STOCK-FO as of Q2 2018.
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.9M shares
.
Largest 10 shareholders include BB BIOTECH AG (3.51M shares), RA CAPITAL MANAGEMENT, LLC (2.83M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.6M shares), NovaQuest Capital Management, L.L.C. (1.19M shares), LORD, ABBETT & CO. LLC (1.16M shares), JANUS HENDERSON GROUP PLC (1.12M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (700K shares), PRICE T ROWE ASSOCIATES INC /MD/ (675K shares), NORGES BANK (600K shares), and BlackRock Inc. (548K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.